Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 265

1.

Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.

Perakakis N, Flohr F, Kayser G, Thomusch O, Parsons L, Billmann F, von Dobschuetz E, Rondot S, Seufert J, Laubner K.

Hormones (Athens). 2016 Jan-Mar;15(1):113-7. doi: 10.14310/horm.2002.1626.

2.

Menin localization in cell membrane compartment.

He X, Wang L, Yan J, Yuan C, Witze ES, Hua X.

Cancer Biol Ther. 2016;17(1):114-22. doi: 10.1080/15384047.2015.1108497.

3.

Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study.

Jyotsna VP, Malik E, Birla S, Sharma A.

BMC Endocr Disord. 2015 Aug 26;15:44. doi: 10.1186/s12902-015-0041-2.

4.

MEN1 c.825‑1G>A mutation in a family with multiple endocrine neoplasia type 1: A case report.

Ning Z, Wang O, Meng X, Xing X, Xia W, Jiang Y, Li M, Xu Y.

Mol Med Rep. 2015 Oct;12(4):6152-6. doi: 10.3892/mmr.2015.4138. Epub 2015 Jul 29.

PMID:
26239674
5.

MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

Kasaian K, Chindris AM, Wiseman SM, Mungall KL, Zeng T, Tse K, Schein JE, Rivera M, Necela BM, Kachergus JM, Casler JD, Mungall AJ, Moore RA, Marra MA, Copland JA, Thompson EA, Smallridge RC, Jones SJ.

J Clin Endocrinol Metab. 2015 Apr;100(4):E611-5. doi: 10.1210/jc.2014-3622. Epub 2015 Jan 27.

6.

Breast cancer risk in MEN1 - a cancer genetics perspective.

Brennan P.

Clin Endocrinol (Oxf). 2015 Mar;82(3):327-229. doi: 10.1111/cen.12614. Epub 2014 Nov 5.

PMID:
25279812
7.

Breast-cancer predisposition in multiple endocrine neoplasia type 1.

Dreijerink KM, Goudet P, Burgess JR, Valk GD; International Breast Cancer in MEN1 Study Group.

N Engl J Med. 2014 Aug 7;371(6):583-4. doi: 10.1056/NEJMc1406028. No abstract available.

8.

p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?

Nozières C, Zhang CX, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, Cordier-Bussat M, Ruszniewski P, Christin-Maitre S, Murat A, Groussin L, Vezzosi D, Cardot-Bauters C, Hervieu V, Joly MO, Giraud S, Odou MF, Gimenez-Roqueplo AP, Goudet P, Borson-Chazot F, Calender A; Groupe français des tumeurs endocrines (GTE).

Ann Endocrinol (Paris). 2014 Jul;75(3):133-40. doi: 10.1016/j.ando.2014.05.003. Epub 2014 Jul 2.

PMID:
24997771
9.

A novel germline mutation of the MEN1 gene caused multiple endocrine neoplasia type 1 in a Chinese young man and 1 year follow-up.

Liu W, Han X, Hu Z, Zhang X, Chen Y, Zhao Y, Ji L.

Eur Rev Med Pharmacol Sci. 2013 Nov;17(22):3111-6.

10.

MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.

Swarts DR, Scarpa A, Corbo V, Van Criekinge W, van Engeland M, Gatti G, Henfling ME, Papotti M, Perren A, Ramaekers FC, Speel EJ, Volante M.

J Clin Endocrinol Metab. 2014 Feb;99(2):E374-8. doi: 10.1210/jc.2013-2782. Epub 2013 Nov 25.

11.

Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.

Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, Siqueira SA, Glezer A, Bronstein MD, Pereira MA, Jureidini R, Bacchella T, Machado MC, Toledo SP, Lourenço DM Jr.

J Clin Endocrinol Metab. 2014 Jan;99(1):E89-96. doi: 10.1210/jc.2013-1768. Epub 2013 Dec 20.

PMID:
24178797
12.

Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism.

Isakov O, Rinella ES, Olchovsky D, Shimon I, Ostrer H, Shomron N, Friedman E.

Genet Res (Camb). 2013 Aug;95(4):114-20. doi: 10.1017/S0016672313000141.

PMID:
24074368
13.

The significance of MEN1 mutations in pituitary carcinomas.

Cuny T, Barlier A.

Biomark Med. 2013 Aug;7(4):567-9. doi: 10.2217/bmm.13.69. No abstract available.

14.

Menin: a scaffold protein that controls gene expression and cell signaling.

Matkar S, Thiel A, Hua X.

Trends Biochem Sci. 2013 Aug;38(8):394-402. doi: 10.1016/j.tibs.2013.05.005. Epub 2013 Jul 10. Review.

15.

Multiple endocrine neoplasia type 1.

Agarwal SK.

Front Horm Res. 2013;41:1-15. doi: 10.1159/000345666. Epub 2013 Mar 19. Review.

PMID:
23652667
16.

MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.

Fang M, Xia F, Mahalingam M, Virbasius CM, Wajapeyee N, Green MR.

Mol Cell Biol. 2013 Jul;33(13):2635-47. doi: 10.1128/MCB.00167-13. Epub 2013 May 6.

17.

Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).

Gaztambide S, Vazquez F, Castaño L.

Minerva Endocrinol. 2013 Mar;38(1):17-28. Review.

PMID:
23435440
18.

Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.

Nunes VS, Souza GL, Perone D, Conde SJ, Nogueira CR.

Pituitary. 2014 Feb;17(1):30-7. doi: 10.1007/s11102-013-0462-8.

19.

A new double substitution mutation in the MEN1 gene: a limited penetrance and a specific phenotype.

Ullmann U, Unuane D, Velkeniers B, Lissens W, Wuyts W, Bonduelle M.

Eur J Hum Genet. 2013 Jun;21(6):695-7. doi: 10.1038/ejhg.2012.241. Epub 2012 Nov 28.

20.

MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.

Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2012 Dec 31;168(2):119-28. doi: 10.1530/EJE-12-0327. Print 2013 Feb.

Supplemental Content

Support Center